Bangladesh's transition out of the Least Developed Countries (LDC) bracket to a developing nation will bring several ...

BANGLADESH’S pharmaceutical sector has experienced remarkable growth over the past few decades, transforming from a largely ...

IN BANGLADESH, the culture of gift-giving is deeply embedded in our social fabric. We give as gestures of respect, gratitude, ...

As a least developed country, Bangladesh's pharmaceutical industry has flourished by producing medicines with patent benefits under a WTO agreement, while the agro-chemical sector has struggled to ...

Highlights: Bangladesh produces only 41 of 400 needed APIs, relying on imports for 80% Pharma market is worth $2.92b, projected to hit $6.17b in five years Local firms meet 98% of medicine demand, but ...

Bangladesh’s imminent graduation from Least Developed Country (LDC) status marks a significant milestone in its economic ...

Economists and business leaders have urged the Bangladesh government to capitalise on the 90-day suspension of US reciprocal ...